Cargando…

Biomarkers Predicting a Need for Intensive Treatment in Patients with Early Arthritis

The heterogeneous nature of rheumatoid arthritis (RA) complicates early recognition and treatment. In recent years, a growing body of evidence has demonstrated that intervention during the window of opportunity can improve the response to treatment and slow—or even stop—irreversible structural chang...

Descripción completa

Detalles Bibliográficos
Autores principales:	I, González-Álvaro, A.M, Ortiz, I.V, Seoane, R, García-Vicuña, C, Martínez, R.P, Gomariz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298237/ https://www.ncbi.nlm.nih.gov/pubmed/25163741 http://dx.doi.org/10.2174/1381612820666140825123104

Ejemplares similares

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis
por: Seoane, Iria V., et al.
Publicado: (2018)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity
por: Seoane, Iria V., et al.
Publicado: (2016)

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity
por: Seoane, Iria V., et al.
Publicado: (2015)

Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients
por: Villanueva-Romero, R., et al.
Publicado: (2019)

Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity
por: Lamana, Amalia, et al.
Publicado: (2020)

Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
por: Castañeda, Santos, et al.
Publicado: (2017)

Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence
por: Villanueva-Romero, Raúl, et al.
Publicado: (2020)

Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis
por: González-Álvaro, Isidoro, et al.
Publicado: (2011)

Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2020)

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
por: Llorente, Irene, et al.
Publicado: (2017)

The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
por: Villanueva-Romero, Raúl, et al.
Publicado: (2018)

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis
por: Castro-Vazquez, David, et al.
Publicado: (2021)

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance
por: Gomariz, Rosa P., et al.
Publicado: (2019)

The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP
por: Jimeno, Rebeca, et al.
Publicado: (2014)

Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics
por: Regueiro, Cristina, et al.
Publicado: (2019)

The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
por: Fuentelsaz-Romero, Sara, et al.
Publicado: (2021)

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
por: Regueiro, Cristina, et al.
Publicado: (2021)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
por: Juarranz, Yasmina, et al.
Publicado: (2005)

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis
por: Mc Ardle, Angela, et al.
Publicado: (2015)

A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
por: Ibañez, Monica, et al.
Publicado: (2010)

Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients
por: Regueiro, Cristina, et al.
Publicado: (2018)

Does the multi-biomarker disease activity score have diagnostic value in early rheumatoid arthritis and unclassified arthritis?
por: Maijer, Karen I, et al.
Publicado: (2015)

The increasing need for biomarkers in intensive care unit-acquired weakness - are microRNAs the solution?
por: Lugg, Sebastian T, et al.
Publicado: (2015)

Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
por: Pennington, Stephen R., et al.
Publicado: (2021)

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
por: González-Álvaro, Isidoro, et al.
Publicado: (2017)

The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression
por: Lamana, Amalia, et al.
Publicado: (2015)

Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need
por: Honey, Madison I. J., et al.
Publicado: (2021)

Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis
por: Scott, I C, et al.
Publicado: (2016)

A serum metabolic biomarker panel for early rheumatoid arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2023)

Need for therapeutic interventions as a predictor of mortality in intensive care
por: Efendijev, I, et al.
Publicado: (2015)

Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?
por: Fernández-Ortiz, Ana M., et al.
Publicado: (2020)

Changes in Proliferation Kinetics of T Cells: A New Predictive Cellular Biomarkers for Early Rheumatoid Arthritis?
por: Pawłowska, Justyna, et al.
Publicado: (2012)

A novel scale based on biomarkers associated with COVID-19 severity can predict the need for hospitalization and intensive care, as well as enhanced probabilities for mortality
por: Nieto-Ortega, Eduardo, et al.
Publicado: (2023)

Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis
por: Gosselt, Helen R., et al.
Publicado: (2020)

Inhibitory Role of Growth Hormone in the Induction and Progression Phases of Collagen-Induced Arthritis
por: Villares, Ricardo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ucfijef08e00lbuqq12g755ord